ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 63. Num. 9.
Pages 1028-1034 (September 2010)

Prevalence, Clinical Characteristics and Risk of Myocardial Infarction in Patients With Cocaine-Related Chest Pain

Prevalencia, características clínicas y riesgo de infarto de miocardio en pacientes con dolor torácico y consumo de cocaína

Xavier BoschaPablo Loma-OsorioaEduard GuaschaSantiago NoguébJosé T. OrtizaMiquel Sánchezb

Options

Introduction and objectives. To investigate the frequency of recent cocaine use in patients attending an emergency department for acute chest pain, to describe the clinical characteristics of these patients, and to estimate the incidence of acute coronary syndrome in this population. Methods. Observational cohort study using a standard questionnaire that includes items on recent cocaine consumption. Results. During a 1-year period, 1240 patients aged under 55 years presented with chest pain. Of these, 63 (5%) had cocaine-related chest pain (7% of men and 1.8% of women). These patients were younger (35±10 years vs. 39±10 years; P=.002), were more frequently male (87% vs. 62%; P < .001), and were more frequently smokers (59% vs. 35%; P < .001). Patients who had used cocaine recently had a higher incidence of acute myocardial infarction (16 vs. 4%; P < .001), especially ST-segment-elevation myocardial infarction (11.1% vs. 1.6%; P < .01). After adjusting for coronary risk factors, history of cardiovascular disease and previous treatment, the odds ratio for myocardial infarction with recent cocaine consumption was 4.3 (95% confidence interval, 2-9.4). Conclusions. Cocaine-related chest pain is often encountered in emergency departments, especially in men aged under 55 years. It is associated with a four-fold increase in the risk of acute myocardial infarction. All male patients aged under 55 years with acute chest pain should be asked about cocaine use.

Keywords

Cocaine
Myocardial infarction
Chest pain
Acute coronary syndrome
Chest pain unit
Emergency department

INTRODUCTION

The ever increasing consumption of cocaine over the last few years has made Spain one of the greatest consumers, together with the United States and the United Kingdom.1-3 According to the World Drug Report for 2009 published by the UN, 1.4% of the population of Western Europe between the ages of 15 and 64 and 3% of the population of Spain, consume cocaine.1 These percentages are greater in certain age groups, such as secondary school students, in whom cocaine consumption in Spain has quadrupled in the last 10 years.2,3

This alarming increase in cocaine consumption correlates with a corresponding increase in medical consultations. Therefore, in 2005, 75% of the consultations in the Emergency Service caused by illegal drug abuse in a tertiary hospital were due to intoxication by cocaine,4 and in these, chest pain was seen in 8%-16%,5 a fact that is little known and, frequently, undervalued.

The lack of available information on the management and prognosis of these patients,6-11 especially in Europe, and the existence of discrepant data on the incidence of acute myocardial infarction related to cocaine consumption12-19 make it necessary to perform specific studies. The aim of this study was to analyse the prevalence of cocaine consumption in patients who consult for non-traumatic chest pain in a general hospital, to study the clinical characteristics of the patients and to estimate the frequency of acute coronary syndromes in this population.

METHOD

All the patients, in consecutive order, who came in to the chest pain unit (CPU) of a university hospital during the course of the year were assessed. In all patients a standard questionnaire was used to register prospectively their clinical history; it included data on history of diseases, cardiovascular risk factors, previous treatments, characteristics of the pain, physical exam, ECG, blood analysis and treatment given. Specifically, a question on recent consumption of cocaine was included. In this manner we identified those patients who came in to consultation for chest pain who reported consumption of cocaine within the last 24 hours. According to medical criteria, on admittance to the Emergency Service the presence of the main metabolite of cocaine (benzoylecgonine) was assessed by qualitative enzyme immunoassay using the Dade (Behring®) reagent.

Patients

All patients were treated following the usual protocol for the CPU of our centre, the physical, functional, organisational and care characteristics of which have been described above.20

In all cases and after initial clinical assessment and the performance of the first ECG, the initial diagnosis was made of: acute coronary syndrome (ACS) with ST segment elevation (ACSSTE); ACS with no ST elevation (ACSNSTE); possible ACS; non-coronary pain. Group 1 patients were immediately assessed for reperfusion treatment; all group 2 patients were assessed by a cardiologist and appropriate treatment begun; patients in group 4 were discharged or referred to the emergency service to continue their diagnostic process. Patients with a possible ACS and normal ECG remained in the CPU until the observation period of at least 6 hours was complete, having undergone a minimum of 3 serial ECGs and 2 troponin I determinations separated by 6-8 hours. If they were troponin negative, an ECG with stress test was programmed with an imaging technique,21,22 and their admittance was subject to the decision of the cardiologist. After completing the CPU protocol, the patients received a final diagnosis of acute myocardial infarction with ST elevation (STEAMI), or acute myocardial infarction with no ST segment elevation (nonSTEAMI), unstable angina or non-coronary pain. Unstable angina was only diagnosed in those cases having chest pain suggestive of coronary origin and negative troponin, signs of spontaneous ischaemia on the ECG (ST descent, negative T waves) or induced ischaemia with a stress test, or coronary lesions ≥50% in patients with a history of infarction.

Statistical Analysis

The clinical characteristics and the evolution of the cocaine consuming patients were compared with those of non-consumers. To avoid bias in the comparison, and since only 4.5% of the consumer patients were over 54 years of age in comparison with 63% of the non-consumers, only patients under 55 years of age were included in this study.

The qualitative variables are expressed in percentages and were analysed using the chi square test or the Fischer test, accordingly. The quantitative variables are expressed as mean (SD) and the differences were analysed using the Student t test. With the aim of estimating relative risk of infarction associated with recent cocaine consumption, a binary logistical regression analysis was performed and the odds ratio (OR) associated with this variable was calculated, adjusted for coronary risk factor, cardiovascular history of the patients and previous treatment. For the statistical analysis the SPSS 15.0 program for Windows was used.

RESULTS

During the study period a total of 3363 patients consulted the Emergency Service for non-traumatic chest pain; of these 1240 (37%) were less than 55 years of age and formed the study group. Initially 41 patients were diagnosed with ACSSTE, 35 with ACSNSTE, 323 with pain of possible coronary origin, and 841 with non-coronary pain.

Prevalence of Recent Cocaine Consumption

Fifty-three patients admitted having consumed cocaine recently, whereas 10 patients that denied it had a positive analysis for cocaine metabolites in urine. The prevalence of recent cocaine consumption was 5% (63 out of 1240), 7% (55 out of 789) in men and 1.8% (8 out of 451) in women (P<.001). Frequency of consumption in men varied with age, between 2.8% in patients between 45 to 55 years of age and 10% in those under 45 years of age (P<.001). In contrast, the frequency of cocaine consumption in women was similar for all age groups (Figure 1).

Figure 1. Distribution by age and sex of the prevalence of recent cocaine consumption in patients who came in to the emergency service due to acute chest pain. Significant differences can be seen between sexes and age groups. The mean frequency of cocaine consumption in men was 7% and it was inversely proportional to the age of the patients from 45 years upwards (P<.001), whereas in women it was 1.8% independent of age (P=.92)

Clinical Characteristics on Admittance

Previous cocaine consumption was seen in younger patients (35 [10] vs 39 [10] years; P=.002), and more frequently in men (87% vs 62%; P<.001) and smokers (59% vs 35%, P<.001) than non-consumers. No significant differences were seen in other coronary risk factors. Neither were differences seen between both groups as to previous cardiovascular history (13% vs 12%, P=.84), nor in treatment previous to admittance (Table).

The diagnostic orientation on admittance was based on anamnesis, physical exam, and ECG, and was significantly different in patients with and without recent consumption of cocaine, with a greater number of patients suspected of ACS with or without ST segment elevation in the cocaine consuming group (Table).

Final Diagnosis

Among cocaine consuming patients, the 7 patients with an initial diagnosis of ACSSTE were diagnosed with STEAMI, and of the 3 patients with ACSNSTE, 1 was diagnosed with nonSTEAMI and 2 with unstable angina. On the other hand, of the 13 patients with an initial diagnosis of chest pain of possible coronary origin, 2 were troponin positive and were diagnosed with nonSTEAMI; of the remaining 11 patients, 3 were admitted and unstable angina was ruled out, in 6 a diagnostic stress test was performed that ruled out ischaemia and 3 patients refused to carry out the stress test and requested voluntary discharge.

Globally and out of a total of 1240 patients studied and after complete assessment in the CPU, 26 patients (2.1%) were diagnosed with STEAMI, 32 (2.6%) with nonSTEAMI, and 28 (2.3%) with unstable angina. Myocardial infarction was diagnosed in 10 patients with cocaine consumption and 48 patients with no cocaine consumption (16% vs 4%; P<.001). This greater frequency of myocardial infarction was especially due to the number of cases with STEAMI, 7 (11.1%) versus 19 (1.6%) (P<.001) (Figure 2).

Figure 2. Differences in final diagnosis of each type of ACS according to previous cocaine consumption among patients that consulted due to chest pain. The patients who had recently consumed cocaine suffered a higher rate of infarction (17% vs 4%, P<.001) than patients who had not consumed cocaine, especially in cases with STEAMI.

The absolute risk of infarction was directly proportional to age in both groups of patients (P<.001), whereas non-adjusted relative risk of infarction for cocaine consumers in relation to non-consumers was 4.4 (95% CI, 2.1-9.3; P<.001), with no significant difference seen in different age groups (Figure 3).

Figure 3. Frequency of acute myocardial infarction in each age group in patients who came in to the Emergency Service due to acute chest pain, according to whether they had consumed cocaine or not. The absolute risk of infarction was directly proportional to age in both groups of patients (P<.001). The non-adjusted relative risk of myocardial infarction with or without ST segment elevation was 4.4 (95% CI, 2.1-9.3; P<.001) times greater among cocaine consumers in relation to non-consumers, with no significant differences seen between different age groups.

In the multivariate analysis and after adjusting for coronary risk factors, cardiovascular history and previous treatment, the recent consumption of cocaine was associated with an odds ratio of infarction of 4.3 (95% CI, 2-9.4).

Clinical Management

During their stay in the CPU, all patients with infarction and previous consumption of cocaine were treated with aspirin, 60% with clopidogrel, 90% with heparin, 60% with beta-blockers, 90% with nitrates, 10% with calcium antagonists, and 50% with benzodiazepines.

Of the 7 patients with STEAMI, 6 underwent primary angioplasty and 1 patient thrombolysis followed by angioplasty. Coronary angiography was performed in the 3 patients with non STEAMI, 3-vessel disease was seen and treated by surgical revascularisation in 1 patient. The other 2 patients did not have significant lesions; in both cases an echocardiographic study showed the existence of regional anomalies during contraction with preserved ejection fraction. In summary: coronary angiography was performed in 10 patients, 2 had no significant lesions, 3 had 1-vessel disease, 4 had 2-vessel disease, and 1 had 3-vessel disease. Coronary spasm was not seen in any of the patients, and complicated lesions with thrombi were seen in 80% of the patients. A patient with a lower AMI and a history of percutaneous revascularisation with a stent in the LAD had a thrombotic occlusion of the stent and the right coronary artery.

DISCUSSION

We describe the prevalence, clinical characteristics and final diagnosis in a consecutive series of patients with chest pain associated with recent cocaine consumption in patients under 55 years of age that came in to the emergency service due to chest pain. The most significant results were the high rate of recent cocaine consumption in these patients, especially in men, and their quadrupled risk of presenting acute myocardial infarction.

Cocaine Consumption and Consultations Due to Chest Pain

The percentage of patients less than 55 years of age that consulted in the emergency service due to chest pain associated with cocaine consumption was 5%. Globally, in all patients of all ages, the frequency was 2%, a similar percentage to the 1.7% reported in a hospital in the United Kingdom11 and the 2.7% seen in the study Acute Cardiac Ischaemia-Time Insensitive Predictive Instrument (ACITIPI)15 in the USA, in concordance with the greater consumption of cocaine in the general population in these countries.1 Therefore, among patients under 45 years of age the frequency was similar (10% vs 12%).

It is important to highlight that in our study, 19% of the patients did not admit they had taken cocaine in spite of cocaine metabolites being detected in urine. Other studies have shown that between 30% and 50% of the patients with positive cocaine tests in urine do not admit consumption.10,23 Furthermore, in the only study in which a systematic study of urine was performed in all the patients who came in to the emergency service due to chest pain, it was seen that 17% of the patients tested positive.23 Therefore, these rates of prevalence are probably underestimated.

In our study the frequency of cocaine consumption was 4 times greater in men than in women, whereas in other studies the ratio of men to women was 2-3 times greater.15,18,23 On the other hand, we wish to highlight that the prevalence of cocaine consumption among men was markedly different according to age, reaching 10% among those less than 45 years of age, percentages which are similar to those seen in other large studies.15 In contrast, among women the frequency was 1.7% in all age groups.

Questions on Cocaine Consumption in the Emergency Service

The questions on drug consumption in the emergency services tend to be very variable, and, in any case, this factor has much lower values than the classical factors of coronary risk.8,9 Therefore, in 1 study only 31% of the patients seen in the emergency service for chest pain were asked if they had consumed cocaine, and this fact was only registered in the clinical history of 13% of the patients.8 In another recent study carried out in the United Kingdom,9 specific questions on cocaine consumption were only carried out with 3.7% of the patients. In contrast, one of the strong points of our study was the application of a standard questionnaire that ensured questions were asked on this factor and registered in the patients' clinical history.

Myocardial Infarction and Recent Cocaine Consumption

Of the patients who consulted due to chest pain after having consumed cocaine 17% suffered an infarction. This high incidence rate of infarction contrasts with what has been seen in other studies that found a wide variability between 1% and 16%.12-19 Differences in the type of population studied, in the consumption pattern or in the necrosis marker used may explain the greater incidence of infarction in our series. It must be pointed out that in 2 recent studies17,19 that used troponin as a marker of myocardial necrosis, myocardial infarction was diagnosed in 14% and 16% of the patients, respectively.

In our study, the patients with chest pain associated with cocaine consumption had a mean age of 35 years and few coronary risk factors. Nonetheless, they had a high incidence of myocardial infarction, especially with ST segment elevation. The risk of infarction adjusted by risk factors, cardiovascular history and previous treatment, was 4 times greater in patients with recent cocaine consumption than in the control group, independent of the age of the patients. This agrees with the data of other large studies that have reported that the risk of infarction in these patients is much greater and can be increased by a factor of 7 in patients less than 45 years of age.24 Furthermore, the probability of suffering an infarction in the hour following cocaine consumption is up to 24 times greater.25

Multiple mechanisms have been proposed as the cause of acute coronary syndrome due to cocaine consumption. Cocaine increases oxygen consumption by inducing tachycardia, arterial blood pressure elevation and increase in myocardial contractility,26 and induces coronary vasoconstriction,27 which could explain the reason approximately 20% of patients with infarction after cocaine consumption have normal coronary vessels.28,29 Furthermore, cocaine induces coronary thrombosis by stimulating platelet activation and aggregation30,31 and the generation of C reactive protein, fibrinogen, von Willebrand32 factor and inhibitor of plasminogen activator.33 The high prevalence of infarction and the thrombotic lesions seen in coronary angiography in the patients of our series illustrate this situation. Lastly, the high prevalence of smokers in this population, a factor which has been considered a coadjuvant for cardiovascular toxicity due to cocaine, must be noted.26

Management of Patients With Chest Pain Associated With Cocaine Consumption

The patients of our study that were diagnosed on admittance with possible ACS were managed according to the usual protocol used in the CPU, with repetition of ECG and troponin tests at 6-8 hours. This rapid observation strategy has been shown to be safe in patients that had consumed cocaine.16,18

In our study, no different management strategy was applied to patients with chest pain and previous cocaine consumption, probably due to the lack of specific studies in this patient population and the European Clinical Guidelines lack of attention to this factor.6,7 Recently the American Heart Association34 has published a document on the management of these patients. The most important recommendations are to use nitrates and calcium antagonists, as well as the performance of emergency coronary angiography if there is persistent ST segment elevation, or preferably when there are persistent electrical changes.

Limitations of the Study

The determination of cocaine metabolites in urine was performed according to clinical judgment, therefore there was probably an underestimation of the real prevalence of recent consumption of cocaine in our series. However, the use and compliance with a standardised clinical questionnaire ensured that specific questions on this factor were asked of all patients.

CONCLUSIONS

The consumption of cocaine is a growing social and medical problem, constituing 5% of the consultations in the emergency service for chest pain in patients under 55 years of age. In spite of the low prevalence of cardiovascular risk factors in these patients they have a 4 times greater risk of myocardial infarction.

To question patients concretely on this factor during chest pain assessment in the emergency service not only makes risk stratification for ACS possible, but also has important therapeutic implications. Therefore, the assessment of cocaine consumption must be included in future guides for care of patients with chest pain and ACS by the different scientific societies and must be generalised in daily clinical practice.

ABBREVIATIONS
ACS: acute coronary syndrome
CPU: chest pain unit
NSTEACS: non-ST-elevation acute coronary syndrome
NSTEMI: non-ST-elevation acute myocardial infarction
STEACS: ST-elevation acute coronary syndrome
STEMI: ST-elevation acute myocardial infarction

Full English text available from: www.revespcardiol.org

SEE EDITORIAL ON PAGES 1013-4


Study funded in part by FIS 07/0089.

Correspondence: Dr. X. Bosch.
Unidad Coronaria. Servicio de Cardiología. Hospital Clínic. Villarroel, 170. 08036. Barcelona. Spain
E-mail: xbosch@clinic.ub.es

Received February 2, 2010.
Accepted for publication April 28, 2010.

Bibliography
[1]
World Drug Report 2009..
United Nations Office for Drugs and Crime. Disponible en: http://www.unodc..
org/unodc/en/ data-and-analysis/WDR-2009, (html),
[2]
Delegación del Gobierno para el Plan Nacional sobre Drogas..
Plan Nacional sobre Drogas. Memoria 2007. Madrid: Ministerio de Sanidad y Consumo. Disponible en: http://www. pnsd.msps..
es/Categoria2/publica/pdf/memo2007, (pdf),
[3]
Observatorio Europeo de las Drogas y las Toxicomanías..
Informe anual 2006. El problema de la drogodependencia en Europa. Disponible en: http://ar2006.emcdda.europa..
eu/es/ home-es, (html),
[4]
Sanjurjo E, Montori E, Nogué S, Sanchez M, Munné P..
Urgencias por cocaína: un problema emergente..
Med Clin (Barc), (2006), 126 pp. 616-9
[5]
Barrio Anta G, Rodríguez Arenas M, Fuente de Hoz L, Royuala Morales L..
Urgencias en consumidores de cocaína en varios hospitales españoles: primeras evidencias de complicaciones agudas por consumo de crack..
Med Clin (Barc), (1998), 111 pp. 49-55
[6]
Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al..
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology..
Eur Heart J, (2007), 28 pp. 1598-660
[7]
Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al..
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology..
Eur Heart J, (2008), 29 pp. 2909-45
[8]
Hollander JE, Brooks DE, Valentine SM..
Assessment of cocaine use in patients with chest pain syndromes..
Arch Intern Med, (1998), 158 pp. 62-6
[9]
Wood DM, Hill D, Gunasekera A, Greene SL, Jones AL, Dargan PI..
Is cocaine use recognised as a risk factor for acute coronary syndrome by doctors in the UK? Postgrad Med J..
, (2007), 83 pp. 325-8
[10]
Lee MO, Vivier PM, Diercks DB..
Is the self-report of recent cocaine or metamphetamine use reliable in illicit stimulant drug users who present to the emergency department with chest pain? J Emerg Med..
, (2009), 37 pp. 237-41
[11]
Bishop CR, Dargan PI, Greene SL, Garnham F, Wood DM..
Emergency department presentations with suspected acute coronary syndrome —frequency of self-reported cocaine use..
Eur J Emerg Med, (2010), 17 pp. 164-6
[12]
Tokarski GF, Paganussi P, Urbanski R, Carden D, Foreback C, Tomlanovich MC..
An evaluation of cocaine-induced chest pain..
Ann Emerg Med, (1990), 19 pp. 1088-92
[13]
Zimmerman JL, Dellinger RP, Majid PA..
Cocaine-associated chest pain..
Ann Emerg Med, (1991), 20 pp. 611-5
[14]
Hollander JE, Hoffman RS, Gennis P, Fairweather P, DiSano MJ, Schumb DA, et al..
Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group..
Acad Emerg Med, (1994), 1 pp. 330-9
[15]
Feldman JA, Fish SS, Beshansky JR, Griffith JL, Woolard RH, Selker HP..
Acute cardiac ischemia in patients with cocaine-associated complaints: Results of a multicenter trial..
Ann Emerg Med, (2000), 36 pp. 469-76
[16]
Kushman SO, Storrow AB, Liu T, Gibler WB..
Cocaine-associated chest pain in a chest pain center..
Am J Cardiol, (2000), 85 pp. 394-6
[17]
Kontos MC, Anderson P, Ornato JP, Tatum JL, Jesse RL..
Utility of troponin I in patients with cocaine-associated chest pain..
Acad Emerg Med, (2002), 9 pp. 1007-13
[18]
Weber JE, Shofer FS, Larkin GL, Kalaria AS, Hollander JE..
Validation of a brief observation period for patients with cocaine-associated chest pain..
N Engl J Med, (2003), 348 pp. 510-7
[19]
Bansal D, Eigenbrodt M, Gupta E, Mehta J..
Traditional risk factors and acute myocardial infarction in patients hospitalized with cocaine-associated chest pain..
Clin Cardiol, (2007), 30 pp. 290-4
[20]
Bragulat E, López B, Miró O, Coll-Vinent B, Jimenez S, Aparicio M, et al..
Análisis de la actividad de una unidad estructural de dolor torácico en un servicio de urgencias hospitalario..
Rev Esp Cardiol, (2007), 60 pp. 276-84
[21]
Sanchis J, Bodí V, Núñez J, Bosch X, Loma-Osorio P, Mainar L, et al..
Limitations of clinical history for evaluation of patients with acute chest pain, non-diagnostic electrocardiogram, and normal troponin..
Am J Cardiol, (2008), 101 pp. 613-7
[22]
Sanchis J, Bodí V, Núñez J, Bertomeu-González V, Gómez C, Consuegra L, et al..
Usefulness of early exercise testing and clinical risk score for prognostic evaluation in chest pain units without evidence of myocardial ischemia..
Am J Cardiol, (2006), 97 pp. 633-5
[23]
Hollander JE, Todd KH, Green G, Heilpern KL, Karras DJ, Singer AJ, et al..
Chest pain associated with cocaine: An assessment of prevalence in suburban and urban emergency departments..
Ann Emerg Med, (1995), 26 pp. 671-6
[24]
Qureshi AI, Suri MF, Guterman LR, Hopkins LN..
Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: Data from the third national health and nutrition examination survey..
Circulation, (2001), 103 pp. 502-6
[25]
Mittleman MA, Mintzer D, Maclure M, Tofler GH, Sherwood JB, Muller JE..
Triggering of myocardial infarction by cocaine..
Circulation, (1999), 99 pp. 2737-41
[26]
Boehrer JD, Moliterno DJ, Willard JE, Snyder RW 2n.d, Horton RP, Glamann DB, et al..
Hemodynamic effects of intranasal cocaine in humans..
J Am Coll Cardiol, (1992), 20 pp. 90-3
[27]
Moliterno DJ, Willard JE, Lange RA, Negus BH, Boehrer JD, Glamann DB, et al..
Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both..
N Engl J Med, (1994), 330 pp. 454-9
[28]
Kontos MC, Jesse RL, Tatum JL, Ornato JP..
Coronary angiographic findings in patients with cocaine-associated chest pain..
J Emerg Med, (2003), 24 pp. 9-13
[29]
Rodríguez-Esteban M, Mesa-Fumero J, Facenda-Lorenzo M, Dorta-Macías C, Ramos-López M, Soriano-Vela E..
Síndrome coronario agudo y cocaína..
Med Clin (Barc), (2009), 133 pp. 132-4
[30]
Kugelmass AD, Oda A, Monahan K, Cabral C, Ware JA..
Activation of human platelets by cocaine..
Circulation, (1993), 88 pp. 876-83
[31]
Rezkalla SH, Mazza JJ, Kloner RA, Tillema V, Chang SH..
Effects of cocaine on human platelets in healthy subjects..
Am J Cardiol, (1993), 72 pp. 243-6
[32]
Siegel AJ, Mendelson JH, Sholar MB, McDonald JC, Lewandrowski KB, Lewandrowski EL, et al..
Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen..
Am J Cardiol, (2002), 89 pp. 1133-5
[33]
Moliterno DJ, Lange RA, Gerard RD, Willard JE, Lackner C, Hillis LD..
Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis..
Am J Med, (1994), 96 pp. 492-6
[34]
McCord J, Jneid H, Hollander JE, De Lemos JA, Cercek B, Hsue P, et al..
Management of cocaine-associated chest pain and myocardial infarction. A scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology..
Circulation, (2008), 117 pp. 1897-907
Are you a healthcare professional authorized to prescribe or dispense medications?